Quote:
Originally Posted by nsw43
This investigational drug has been given "Fast Track" status by the FDA, which might make it available in the US by the end of 2014:
|
Investigational? This is long overdue considering it's been in use in 25 other countries (including Canada) for
years. In the US, Sativex has been stalled in the limbo known Phase III trials for longer than most medications—IMO for political rather than medical/science reasons.
I don't want to be "Captain Bringdown", but let's not get too excited... yet; according to the article,
initial data from the Phase III trials is expected around the end of this year. I don't know the average lag between that and actual availability for prescription/use—
if they decide the data passes muster. MrsD/anyone? There may still be other obstacles.
Doc